Brief Reports
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 15, 2000; 6(1): 150-152
Published online Feb 15, 2000. doi: 10.3748/wjg.v6.i1.150
Chronic ulcerative colitis model in rats
Li Zheng, Zhen-Qiang Gao, Shu-Xian Wang
Li Zheng, Department of Pharmacology, National Institutes Pharmaceutical Research and Development, Beijing 102206, China
Zhen-Qiang Gao, Department of Pathology, Beijing Medical University, Beijing 100083, China
Shu-Xian Wang, National Administrative Center of New Drug Research, Beijing 100810, China
Li Zheng, male, born on 1965-09-01 in Hubei Province, graduated from China Pharmaceutical University, now associate professor of gastroenterology, having 14 papers published.
Author contributions: All authors contributed equally to the work.
Supported by the National “Eighth Five-Year Plan” Program, No. 85-922-01.
Correspondence to: Li Zheng, National Institutes Pharmaceutical Research and Development, Beijing 102206, China. nipzl@263.net or zwl@cenpok.net
Telephone: +86-10-69732071 Fax: +86-10-69731050
Received: August 11, 1999
Revised: September 26, 1999
Accepted: October 22, 1999
Published online: February 15, 2000

Abstract
Key Words: colitis, ulcerative, disease model, animal, rats



INTRODUCTION

In recent years, there have been many reports about animal model to investigate drugs for inflammatory bowel diseases (IBD). The experimental animal model often used is acetic acid-induced damage of colonic muscosa. In the present study, this animal model was investigated by administering various concentrations of TNBS.

MATERIALS AND METHODS
Materials

Animals Wistar male and female rats weighing 258 g ± 25 g were used in this study. They were provided by the Department of Experimental Animals of Beijing Medical University. They were housed in rack-mounted cages with a maximum of 6 rats, and were fasted for 12 h with access to waterad libitum before experiment.

Reagent Fifty mmol/L (pH = 6.0) phosphate buffer. 0.5 % hexadecyltrimethylammonium bromide (HTAB, Beijing Xizhong Chemical Plant) in 50 mmol/L (pH = 6.0) phosphate buffer, 50 mmol/L (pH = 6.0) phosphate buffer containing 16.7% (g/L) o-dianisidine Dihydrochloride (Sigma chemical Co.) and 0.0005% hydrogen peroxide, TNBS (Sigma chemical Co. 5% w/v solution) solution of 30% ethanol, 20% (w/v) ethyl carbarnate in 0.9% saline.

Instrument T25 Ultra-tukrax (German, JANKE & KUNKEL IKA-Labortechnik ). 4710 series Ultrasonic homogenizer (Cole-Parmer Inst rument Co. America), GL20A Refrigerated Centrifuge (Hunan Instrument and Meter Plant China), UV-260 Spectrophometer ( Shimuduzu Co. Japan ), PHSJ-4 pH meter (Shanghai Leici Instrument Plant China), Libror EB-2080M Lectronic Animal Balance (Shimuduzu Co. Japan).

Methods

Effect of various TNBS doses on myeloperoxidase (MPO) activity, colon damage and weight A total of 30 rats were randomized into five groups, 6 rats each group (in a cage), consisting of a 30% ethanol control group as well as four dose TNBS groups. The animals were anesthetized with 20% ethyl carbarnat e (ip, 6 mL/kg), and 0.5 mL of either 30% ethanol (controls) or various concentrations of TNBS was slowly administered into the lumen of the colon via the anus using a rubber catheter (12 cm long, external diameter 2 mm). The rats were killed after 3wk, and the distal colon (8 cm) was removed, opened longitudinally and washed to remove lumina contents, colon wet weight was weighed, and colonic injuries were evaluated. The excised colon was pinned out on a wax block washed with 0.9% saline and assigned a code number. The colon was immediately examined under a stereomicroscope and any visible damage was scored on a 0-5 scale (Table 1). Small sections of colon were taken from two distinct areas from each colon and placed in 10% formalin for histological examination. The colon was fixed, cut longitudinally into 5ìm sections, stained with hematoxylin and eosin. The second segment (200 mg-400 mg) was immediately frozen for subsequent estimation of MPO activity[1].

Table 1 Criteria for scoring the gross morphologic damage.
ScoreGross morphology
0No damage
1Localized hyperemia with no ulcers.
2Liner ulcers with no significant inflammation.
3Liner ulcers with inflammation at one site.
4More sites of ulcers and inflammation, the size of ulcers < 1 cm
5Multiple inflammations and ulcers, the size of ulcers ≥ 1 cm

The relationship of MPO and time-course Based on the results of dose-response studies, the dose of TNBS used in subsequent experiments was 100 mg/kg per rat. A total of 40 rats (5 rats per cage) administered a single intracolonic dose of TNBS ethanol solution (0.5 mL/rat). In control experiments, 5 rats received 0.5 mL 30% ethanol. At various times (24 h and 1 wk-8 wk) after intracolonic administration of TNBS or one of the control solutions, 5 rats from each treatment group were randomly selected and killed, the colon tissue MPO activity was determined as the indices of inf lammation.

Statistical analysis The data were expressed as -x ± s, and analyzed using the Student’s t test to compare the difference.

RESULTS
Assessment of MPO activity, colonic weight and damage score

The severity of colonic damage induced by TNBS increased with the dose (Figure 1). Rats that received the lowest dose of TNBS (25 mg/kg) had damage scores, colon weights and tissue levels of MPO activity were not significantly different from the control animals treated only with 30% ethanol vehicle (P > 0.05). When doses of TNBS (50 mg/kg-150 mg/kg ) were used, the damage scores, colon weights and tissue levels of MPO activity increased in a dose-related manner and there was a significant difference compared with control (30% ethanol).

Figure 1
Figure 1 Rats were killed 3wk after intracolon ic administration of 25 mg/kg-150 mg/kg of TNBS. Colonic damage, colon weight and tissue MPO activity were assayed. Data of TNBS-treated rats were compared with control (30% ethanol) group by Student’s t test, aP < 0.05, bP < 0.01.
Histological examination

Three weeks after TNBS/ethanol administration, the bowel wall was basically normal in the 25 mg/kg group, and “string of beads” was found in 1 rat. Medium hemorrhage, edema and ulcers, cryptoabscess in the mucosa were observed in animals that received 50 mg/kg of TNBS, in TNBS group (100 mg/kg), the bowel lumen became narrow with thickened wall (2 mm-3 mm), on the bowel lumen mucosal surface area there was adherent membrane with brown black, liner ulcers (1 mm-6 mm), proliferous lymphocyte tissue, inflammatory granulomas and submucosal neutrophils infiltration. Macrophages, lymphocytes, fibroblasts, and cryptoabscess were also observed. The TNBS (150 mg/kg) group had noticeable ulcers and inflammatory granulomas in their colon, neutrophil infiltration was obviously observed in mucosa and sub mucosa extensive necrosis of the colonic mucosa and exfoliation of the epithelia were found in other rats with intact muscularis. In cases of severe ulcers, the colon had often adhered to surrounding intestinal tissues and abdominal wall (Figure 2).

Figure 2
Figure 2 Histological findings in ulcerative colitis induced by different doses of TNBS ethanol. a: TNBS 25 mg/kg, the mucosa is normal. b: TNBS 50 g/kg, small mucosal ulc ers and cryptoabscess formation. c-d: TNBS 100 mg/kg, mucosal ulcers, in flammatory exudate, proliferous granulomas and cells infiltration. e-f: TNBS 150 g/kg, gross ulcers and proliferous granulomas, necrosis of epithelium at mu cosal sueface and inflammatory cell infiltration (He, × 100)
Time-course study

A single instillation of TNBS at the dose of 100 mg/kg into the rat colon produced chronic ulcers and inflammation which had persisted for up to 7 wk. MPO activity reached a maximum value at 3 wk after TNBS, and was followed by a gradual reduction in activity. At 3 wk the MPO value was at near baseline level (Figure 3).

Figure 3
Figure 3 The effects of intracolonic administration of 100 mg/kg of TNBS on MPO activity 1 wk-8 wk after administration. Each bar represents the -x ± s of 5 animals. All data for TNBS-tr eated rats were compared with 0 wk (control group). aP < 0.05, bP < 0.01.
DISCUSSION

TNBS is a hapten, when it is bound with a substance of high molecular tissue proteins, it will turn into a antigen. It has been shown that it can elicit immunologic responses, induce generation of colitis[2,3]. The histological features of the animals received TNBS (50 mg/kg-150 mg/kg) were chronic inflammation, relatively long duration of inflammation and changes in various inflammatory mediators such as prostaglandin E2, thromboxane B2, leukotriene B4, 6-keto-prostaglandin F, leukotriene C4, plet elet-activating factor and interleukin. This model is characterized by the simple process and reproducible colonic damage, inexpensive and short duration of the experiment, long-lasting damage with inflammatory cell infiltration and ulcers. Thus, the model is rather suitable for the assessment of the effects of potential agents. In the present study, the dose of TNBS producing a moderate colonic inflammation and ulcers was about 100 mg/kg, the severity of colonic inflammation induced by TNBS increased with the dose administered. So a TNBS dose of 100 mg/kg was chosen for an appropriate experimental dose, the results were similar to the reports in the literature[4,5].

There was extensive colonic muscosal and submuscosal damage characterized by infiltration of inflammatory cells and ulcers after different doses of TNBS ( 50 mg/kg-150 mg/kg ) were administered into the colons of rats. After the animals received TNBS ( 100 mg/kg ), in acute phase, extensive infiltration of inflammatory cells constituted the main part; in chronic phase, the inflammatory granulomas and ulcers induced by TNBS made up the main part. MPO is an enzyme found in the neutrophils, and can be used as a quantitative index of inflamm ation in colonic tissue[1]. MPO activity may be regarded as an index of inflammation damage[6].

Footnotes

Edited by Wang XL

References
1.  Zheng L, Wang SX, Cui DY, Cui YY. A simple method of assessing inflammatory bowel disease. Zhongguo Yaolixue Tongbao. 1996;12:468-469.  [PubMed]  [DOI]
2.  Little JR, Eisen HN. Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry. 1966;5:3385-3395.  [PubMed]  [DOI]
3.  Fidler JM. Induction of hapten-specific immunological tolerance and immunity in B lymphocytes. VII. Correlation between trinitrobenzenesulfonic acid administration, serum trinitrophenyl content, and level of tolerance. Cell Immunol. 1985;94:285-291.  [PubMed]  [DOI]
4.  Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984;86:453-460.  [PubMed]  [DOI]
5.  Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology. 1991;101:540-547.  [PubMed]  [DOI]
6.  Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984;87:1344-1350.  [PubMed]  [DOI]